Cladribine Intravenous and Hyaluronate and Derivatives
Determining the interaction of Cladribine Intravenous and Hyaluronate and Derivatives and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine Intravenous-Hyaluronate and Derivatives Injection (Knee)
- Cladribine Intravenous-Hyaluronate sodium Injection
- Cladribine Intravenous-Hyaluronidase
- Cladribine Intravenous-Hyaluronidase and immune globulin
- Cladribine Intravenous-Hyaluronidase and rituximab
- Cladribine Intravenous-Hyaluronidase and trastuzumab
- Hyaluronate and Derivatives-Cladribine Tablets
- Hyaluronate and Derivatives-Claforan
- Hyaluronate and Derivatives-Claforan in D5W
- Hyaluronate and Derivatives-Claravis
- Hyaluronate and Derivatives-Clarifoam EF
- Hyaluronate and Derivatives-Clarinex